课题基金 / 基金详情

Role of Deamidation in Human Beta-Crystallin Structure

Role of Deamidation in Human Beta-Crystallin Structure
脱酰胺在人 β-晶状体蛋白结构中的作用
批准号:
6874875
负责人:
KIRSTEN Jeanne LAMPI
金额:
$25.41万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2008-03-31

项目摘要

项目成果

KIRSTEN Jeanne LAMPI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):脱酰胺是晶状体中最常见的翻译后修饰,并随着年龄的增长而增加。所有主要的晶体蛋白都被脱酰胺,β -晶体蛋白是脱酰胺最严重的。我们的实验室最近确定了晶体蛋白中几个特定的体内脱酰胺位点,使我们能够研究这种修饰的功能后果。几个脱酰胺位点位于β亚基之间的高度保守区域,表明这些脱酰胺发生在关键结构区域。然而,脱酰胺对晶体结构和稳定性的影响尚不清楚。晶体蛋白的稳定性是晶状体透明度的基础。只有当我们开始阐明时,白内障的形成才会被理解
英文摘要
DESCRIPTION (provided by applicant): Deamidation is the most prevalent post-translational modification in the lens, and increases with age. All of the major crystallins are deamidated, with the beta-crystallins the most heavily deamidated. Our laboratory has recently identified several specific in vivo sites of deamidation in crystallins allowing us to investigate the functional consequences of this modification. Several deamidation sites are in highly conserved regions between beta-subunits, suggesting that these deamidations occur in critical structural regions. However, the effects of deamidation on crystallin structure and stability are not known. The stability of crystallins is fundamental to the transparency of the lens. The formation of cataracts will only be understood when we begin to elucidate factors that alter crystallin stability. The long-term goal of our research is to determine the effects of deamidation on beta-crystallins in the human lens. The objective of this grant application is to characterize several specific in vivo sites of deamidation of beta-crystallins. We hypothesize that deamidation in critical regions disrupt structure and stability promoting insolubilization, while deamidations in non-critical regions foster solubility. Our hypothesis is derived from our previous studies showing that a deamidation at the interface between domains decreased stability, while deamidations at other sites increased stability, or had little effect. To test our hypothesis, we will use site directed mutagenesis to introduce in vivo deamidations in regions predicted to be structurally significantly. We will then characterize their structure, stability, and tendency to aggregate using advanced biophysical techniques, such as multi-angle laser light scattering, and dynamic light scattering. Only after we understand how deamidation alters crystallin structure can we correlate specific deamidations to cataract formation. We can then begin to investigate methods to prevent deamidation or design chaperones that prevent structural changes at these sites.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Opening Dental and Oral Research Summers (DORS) to Scientific Careers throughout Oregon
  • 批准号:
    10598424
  • 项目类别:
  • 资助金额:
    $12.75万
  • 财政年份:
    2023
  • 负责人:
    KIRSTEN Jeanne LAMPI
  • 依托单位:
Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
  • 批准号:
    10298668
  • 项目类别:
  • 资助金额:
    $39.85万
  • 财政年份:
    2016
  • 负责人:
    KIRSTEN Jeanne LAMPI
  • 依托单位:
Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
  • 批准号:
    10655486
  • 项目类别:
  • 资助金额:
    $37.15万
  • 财政年份:
    2016
  • 负责人:
    KIRSTEN Jeanne LAMPI
  • 依托单位:
Aggregation of Deamidated Crystallins as a Major Cause of Cataracts
  • 批准号:
    10468857
  • 项目类别:
  • 资助金额:
    $36.04万
  • 财政年份:
    2016
  • 负责人:
    KIRSTEN Jeanne LAMPI
  • 依托单位:
海外基金